## Abstract Dopamine agonists are used as initial treatment in patients with Parkinson's disease (PD) to reduce incidence and severity of motor complications. This paradigm is based on long‐term studies, allowing “rescue” therapy with levodopa. The present strict monotherapy study (PELMOPET, the ac
Levodopa monotherapy can induce “sleep attacks” in Parkinson's disease patients
✍ Scribed by Joaquim J. Ferreira; Claire Thalamas; Jean Louis Montastruc; Alexandre Castro-Caldas; Olivier Rascol
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 98 KB
- Volume
- 248
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Genes encoding proteins involved in dopaminergic transmission are potential candidate genes for the induction of somnolence in Parkinson's disease (PD) because dopaminergic agents have been shown to be associated with sudden onset of sleep (SOS) in PD. We conducted an association study
## Abstract We describe a sleep attack, which was induced by taking excessive levodopa and pergolide, in a 73‐year‐old woman with Parkinson's disease. At the onset of the sleep attack, her head suddenly sagged and sometimes hit the table, but she did not notice these symptoms. Her family noticed th
## Abstract Levodopa‐induced ocular dyskinesias are very uncommon. Usually they occur simultaneously with limb peak‐dose choreatic dyskinesias. We report on a patient with leftward and upward deviations of gaze during the peak effect of levodopa, and hypothesize that a severe dopaminergic denervati